Skip to main content
Erschienen in: International Orthopaedics 6/2006

01.12.2006 | Review

Pathology of primary malignant bone and cartilage tumours

verfasst von: L. B. Rozeman, A. M. Cleton-Jansen, P. C. W. Hogendoorn

Erschienen in: International Orthopaedics | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Bone- and cartilage-forming tumours (osteosarcomas and chondrosarcomas) are rare malignant neoplasms. These tumours are clinically aggressive and often need extensive local and/or systemic treatment. Whereas no other treatment but surgery is currently available for chondrosarcomas, osteosarcomas show an approximately 50–80% response rate to adjuvant chemotherapy. Surgical removal of these tumours is currently mostly performed with limb salvage, but amputation may be required in some cases. In addition, the tumours have a risk of local recurrences adversely affecting the prognosis compared to the primary tumour. In this report we will mainly focus on two of the most prevalent malignant bone tumours, conventional osteosarcoma and conventional chondrosarcoma, and use these to illustrate the problems with the diagnosis of bone sarcomas in general.
Literatur
1.
Zurück zum Zitat Anninga JK, Van de Vijver MJ, Cleton-Jansen AM, Kristel PMP, Taminiau AHM, Nooij M, Egeler RM, Hogendoorn PCW (2004) Overexpression of the Her-2 oncogene does not play a role in high-grade osteosarcomas. Eur J Cancer 40:963–970PubMedCrossRef Anninga JK, Van de Vijver MJ, Cleton-Jansen AM, Kristel PMP, Taminiau AHM, Nooij M, Egeler RM, Hogendoorn PCW (2004) Overexpression of the Her-2 oncogene does not play a role in high-grade osteosarcomas. Eur J Cancer 40:963–970PubMedCrossRef
2.
Zurück zum Zitat Bertoni F, Bacchini P, Hogendoorn PCW (2002) Chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds) World Health Organisation classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 247–251 Bertoni F, Bacchini P, Hogendoorn PCW (2002) Chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds) World Health Organisation classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 247–251
3.
Zurück zum Zitat Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H, Winkler K (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols. J Clin Oncol 20:776–790PubMedCrossRef Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H, Winkler K (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols. J Clin Oncol 20:776–790PubMedCrossRef
4.
Zurück zum Zitat Bovée JVMG, Cleton-Jansen AM, Rosenberg C, Taminiau AHM, Cornelisse CJ, Hogendoorn PCW (1999) Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol 189:454–462PubMedCrossRef Bovée JVMG, Cleton-Jansen AM, Rosenberg C, Taminiau AHM, Cornelisse CJ, Hogendoorn PCW (1999) Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol 189:454–462PubMedCrossRef
5.
Zurück zum Zitat Bovée JVMG, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW (2005) Emerging pathways in the development of chondrosarcoma of bone and the implications for targeted treatment. Lancet Oncol 6:599–607PubMedCrossRef Bovée JVMG, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW (2005) Emerging pathways in the development of chondrosarcoma of bone and the implications for targeted treatment. Lancet Oncol 6:599–607PubMedCrossRef
6.
Zurück zum Zitat Bovée JVMG, Royen Mv, Bardoel AFJ, Rosenberg C, Cornelisse CJ, Cleton-Jansen AM, Hogendoorn PCW (2000) Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol 157:1587–1595PubMed Bovée JVMG, Royen Mv, Bardoel AFJ, Rosenberg C, Cornelisse CJ, Cleton-Jansen AM, Hogendoorn PCW (2000) Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol 157:1587–1595PubMed
7.
Zurück zum Zitat Burak Z, Moretti JL, Ersoy O, Sanli U, Kantar M, Tamgac F, Basdemir G (2003) 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression. J Nucl Med 44:1394–1401PubMed Burak Z, Moretti JL, Ersoy O, Sanli U, Kantar M, Tamgac F, Basdemir G (2003) 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression. J Nucl Med 44:1394–1401PubMed
8.
Zurück zum Zitat Chow WA, Bedell V, Gaytan P, Borden E, Goldblum J, Hicks D, Slovak ML (2006) Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas. Cancer Genet Cytogenet 166:95–100PubMedCrossRef Chow WA, Bedell V, Gaytan P, Borden E, Goldblum J, Hicks D, Slovak ML (2006) Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas. Cancer Genet Cytogenet 166:95–100PubMedCrossRef
9.
Zurück zum Zitat Cleton-Jansen AM, van Beerendonk HM, Baelde HJ, Bovée JVMG, Karperien M, Hogendoorn PCW (2005) Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Clin Cancer Res 11:8028–8035PubMedCrossRef Cleton-Jansen AM, van Beerendonk HM, Baelde HJ, Bovée JVMG, Karperien M, Hogendoorn PCW (2005) Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Clin Cancer Res 11:8028–8035PubMedCrossRef
10.
Zurück zum Zitat Cleton-Jansen AM, Buerger H, Hogendoorn PCW (2005) Central high-grade osteosarcoma of bone: diagnostic and genetic considerations. Curr Diagn Pathol 11:390–399CrossRef Cleton-Jansen AM, Buerger H, Hogendoorn PCW (2005) Central high-grade osteosarcoma of bone: diagnostic and genetic considerations. Curr Diagn Pathol 11:390–399CrossRef
11.
Zurück zum Zitat Dietlein M, Féaux de Lacroix W, Neufang KFR, Steinbrich W, Schmidt J (1990) Zur Problematik der Dignitätsbeurteilung von Knorpeltumoren langer Rohrenknochen aus radiologischer und pathologischer Sicht. Rontgen Blatt 174:180 Dietlein M, Féaux de Lacroix W, Neufang KFR, Steinbrich W, Schmidt J (1990) Zur Problematik der Dignitätsbeurteilung von Knorpeltumoren langer Rohrenknochen aus radiologischer und pathologischer Sicht. Rontgen Blatt 174:180
12.
Zurück zum Zitat Evans HL, Ayala AG, Romsdahl MM (1977) Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 40:818–831PubMedCrossRef Evans HL, Ayala AG, Romsdahl MM (1977) Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 40:818–831PubMedCrossRef
13.
Zurück zum Zitat Fabbro D, Ruetz S, Buchdunger E, Cowan-Jacob SW, Fendrich G, Liebetanz J, Mestan J, O’Reilly T, Traxler P, Chaudhuri B, Fretz H, Zimmermann J, Meyer T, Caravatti G, Furet P, Manley PW (2002) Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol Ther 93:79–98PubMedCrossRef Fabbro D, Ruetz S, Buchdunger E, Cowan-Jacob SW, Fendrich G, Liebetanz J, Mestan J, O’Reilly T, Traxler P, Chaudhuri B, Fretz H, Zimmermann J, Meyer T, Caravatti G, Furet P, Manley PW (2002) Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol Ther 93:79–98PubMedCrossRef
14.
Zurück zum Zitat Fuchs B, Pritchard DJ (2002) Etiology of osteosarcoma. Clin Orthop Relat Res :40–52 Fuchs B, Pritchard DJ (2002) Etiology of osteosarcoma. Clin Orthop Relat Res :40–52
15.
Zurück zum Zitat Geirnaerdt MJ, Bloem JL, Eulderink F, Hogendoorn PCW, Taminiau AHM (1993) Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings. Radiology 186:813–817PubMed Geirnaerdt MJ, Bloem JL, Eulderink F, Hogendoorn PCW, Taminiau AHM (1993) Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings. Radiology 186:813–817PubMed
16.
Zurück zum Zitat Geirnaerdt MJ, Hogendoorn PCW, Bloem JL, Taminiau AHM, Van der Woude HJ (2000) Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology 214:539–546PubMed Geirnaerdt MJ, Hogendoorn PCW, Bloem JL, Taminiau AHM, Van der Woude HJ (2000) Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology 214:539–546PubMed
17.
Zurück zum Zitat Geirnaerdt MJA, Hermans J, Bloem JL, Kroon HM, Pope TL, Taminiau AHM, Hogendoorn PCW (1997) Usefulness of radiography in differentiating enchondroma from central grade I chondrosarcoma. A J R 169:1097–1104 Geirnaerdt MJA, Hermans J, Bloem JL, Kroon HM, Pope TL, Taminiau AHM, Hogendoorn PCW (1997) Usefulness of radiography in differentiating enchondroma from central grade I chondrosarcoma. A J R 169:1097–1104
18.
Zurück zum Zitat Hauben EI, Arends J, Vandenbroucke JP, van Asperen CJ, Van Marck E, Hogendoorn PC (2003) Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet 11:611–618PubMedCrossRef Hauben EI, Arends J, Vandenbroucke JP, van Asperen CJ, Van Marck E, Hogendoorn PC (2003) Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Eur J Hum Genet 11:611–618PubMedCrossRef
19.
Zurück zum Zitat Hauben EI, Bielack S, Grimer R, Jundt G, Reichardt P, Sydes M, Taminiau AH, Hogendoorn PC (2006) Clinico-histologic parameters of osteosarcoma patients with late relapse. Eur J Cancer 42:460–466PubMedCrossRef Hauben EI, Bielack S, Grimer R, Jundt G, Reichardt P, Sydes M, Taminiau AH, Hogendoorn PC (2006) Clinico-histologic parameters of osteosarcoma patients with late relapse. Eur J Cancer 42:460–466PubMedCrossRef
20.
Zurück zum Zitat Hauben EI, Weeden S, Pringle J, Van Marck EA, Hogendoorn PC (2002) Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 38:1218–1225PubMedCrossRef Hauben EI, Weeden S, Pringle J, Van Marck EA, Hogendoorn PC (2002) Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 38:1218–1225PubMedCrossRef
21.
Zurück zum Zitat Hogendoorn PCW, Bovée JVMG, Karperien M, Cleton-Jansen AM (2003) Skeletogenesis: genetics. In: Cooper DN (ed) Nature encyclopedia of the human genome. Nature Publishing Group, London, pp 306–313 Hogendoorn PCW, Bovée JVMG, Karperien M, Cleton-Jansen AM (2003) Skeletogenesis: genetics. In: Cooper DN (ed) Nature encyclopedia of the human genome. Nature Publishing Group, London, pp 306–313
22.
Zurück zum Zitat Huvos AG (1991) Bone tumors. Diagnosis, treatment, and prognosis, 2nd edn. W.B. Saunders Company, Philadelphia Huvos AG (1991) Bone tumors. Diagnosis, treatment, and prognosis, 2nd edn. W.B. Saunders Company, Philadelphia
23.
Zurück zum Zitat Jiang X, Dutton CM, Qi W, Block JA, Brodt P, Durko M, Scully SP (2003) Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma. J Orthop Res 21:1063–1070PubMedCrossRef Jiang X, Dutton CM, Qi W, Block JA, Brodt P, Durko M, Scully SP (2003) Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma. J Orthop Res 21:1063–1070PubMedCrossRef
24.
Zurück zum Zitat Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10:182–186PubMedCrossRef Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10:182–186PubMedCrossRef
25.
Zurück zum Zitat Lagonigro MS, Tamborini E, Negri T, Staurengo S, Dagrada GP, Miselli F, Gabanti E, Greco A, Casali PG, Carbone A, Pierotti MA, Pilotti S (2006) PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma. J Pathol 208:615–623PubMedCrossRef Lagonigro MS, Tamborini E, Negri T, Staurengo S, Dagrada GP, Miselli F, Gabanti E, Greco A, Casali PG, Carbone A, Pierotti MA, Pilotti S (2006) PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma. J Pathol 208:615–623PubMedCrossRef
26.
Zurück zum Zitat Link MP, Gebhardt MC, Meyers PA (2002) Osteosarcoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott, Williams & Wilkins, Philadelphia, pp 1502–1589 Link MP, Gebhardt MC, Meyers PA (2002) Osteosarcoma. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott, Williams & Wilkins, Philadelphia, pp 1502–1589
27.
Zurück zum Zitat Marina N, Gebhardt M, Teot L, Gorlick R (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9:422–441PubMedCrossRef Marina N, Gebhardt M, Teot L, Gorlick R (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9:422–441PubMedCrossRef
28.
Zurück zum Zitat McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M (2002) Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 8:3584–3591PubMed McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, Fidler IJ, Bar-Eli M (2002) Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 8:3584–3591PubMed
29.
Zurück zum Zitat Mirra JM, Gold R, Downs J, Eckardt JJ (1985) A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin Orthop :214–237 Mirra JM, Gold R, Downs J, Eckardt JJ (1985) A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin Orthop :214–237
30.
Zurück zum Zitat Miyaji T, Nakase T, Onuma E, Sato K, Myoui A, Tomita T, Joyama S, Ariga K, Hashimoto J, Ueda T, Yoshikawa H (2003) Monoclonal antibody to parathyroid hormone-related protein induces differentiation and apoptosis of chondrosarcoma cells. Cancer Lett 199:147–155PubMedCrossRef Miyaji T, Nakase T, Onuma E, Sato K, Myoui A, Tomita T, Joyama S, Ariga K, Hashimoto J, Ueda T, Yoshikawa H (2003) Monoclonal antibody to parathyroid hormone-related protein induces differentiation and apoptosis of chondrosarcoma cells. Cancer Lett 199:147–155PubMedCrossRef
31.
Zurück zum Zitat Morioka H, Weissbach L, Vogel T, Nielsen GP, Faircloth GT, Shao L, Hornicek FJ (2003) Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res 9:1211–1217PubMed Morioka H, Weissbach L, Vogel T, Nielsen GP, Faircloth GT, Shao L, Hornicek FJ (2003) Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res 9:1211–1217PubMed
32.
Zurück zum Zitat O’Flanagan SJ, Stack JP, McGee HMJ, Dervan P, Hurson B (1991) Imaging of intramedullary tumour spread in osteosarcoma. A comparison of techniques. J Bone Jt Surg [Br] 73B:998–1001 O’Flanagan SJ, Stack JP, McGee HMJ, Dervan P, Hurson B (1991) Imaging of intramedullary tumour spread in osteosarcoma. A comparison of techniques. J Bone Jt Surg [Br] 73B:998–1001
33.
Zurück zum Zitat Rizzo M, Ghert MA, Harrelson JM, Scully SP (2001) Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop 391:224–233PubMed Rizzo M, Ghert MA, Harrelson JM, Scully SP (2001) Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop 391:224–233PubMed
34.
Zurück zum Zitat Schiller AL (1985) Diagnosis of borderline cartilage lesions of bone. Semin Diagn Pathol 2:42–62PubMed Schiller AL (1985) Diagnosis of borderline cartilage lesions of bone. Semin Diagn Pathol 2:42–62PubMed
35.
Zurück zum Zitat Van der Woude HJ, Bloem JL, Hogendoorn PCW (1998) Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing’s sarcoma: review of current imaging modalities. Skeletal Radiol 27:57–71PubMedCrossRef Van der Woude HJ, Bloem JL, Hogendoorn PCW (1998) Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing’s sarcoma: review of current imaging modalities. Skeletal Radiol 27:57–71PubMedCrossRef
Metadaten
Titel
Pathology of primary malignant bone and cartilage tumours
verfasst von
L. B. Rozeman
A. M. Cleton-Jansen
P. C. W. Hogendoorn
Publikationsdatum
01.12.2006
Verlag
Springer-Verlag
Erschienen in
International Orthopaedics / Ausgabe 6/2006
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-006-0212-x

Weitere Artikel der Ausgabe 6/2006

International Orthopaedics 6/2006 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.